SCHEMBL5168

SCHEMBL5168

[CH2]COCC1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL446801 0.94
SCHEMBL5386 0.92 SPHK2 (0.37)
SCHEMBL4978 0.92 SPHK2 (0.37)
SCHEMBL5230 0.92 SPHK2 (0.37)
SCHEMBL127921 0.88
SCHEMBL7303667 0.87 SPHK2 (0.35)
SCHEMBL7745542 0.82 SLC1A3 (0.35)
SCHEMBL129491 0.79
SCHEMBL131976 0.77 SPHK1 (0.35)
SCHEMBL6177197 0.77 SLC1A3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3590940-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2021-06-09 EP disclosed
US-10913745-B2 Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors HOFFMANN-LA ROCHE INC. (US) 2021-02-09 US disclosed
US-20210015792-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL HOFFMANN-LA ROCHE INC. (US) 2021-01-21 US disclosed
US-10849881-B2 Octahydro-cyclobuta[1,2-c;3,4-c′]dipyrrol-2-yl HOFFMANN-LA ROCHE INC. (US) 2020-12-01 US disclosed
US-20200339570-A1 BICYCLIC DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2020-10-29 US disclosed
US-20200207769-A1 DIAZASPIROCYCLOALKANE AND AZASPIROCYCLOALKANE HOFFMANN-LA ROCHE INC. (US) 2020-07-02 US disclosed
US-20200199155-A1 CONDENSED [1,4] DIAZEPINE COMPOUNDS AS AUTOTAXIN (ATX) AND LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2020-06-25 US disclosed
EP-2785695-B1 NEW BICYCLIC DIHYDROISOQUINOLINE-1-ONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2020-06-17 EP disclosed
US-10669268-B2 Bicyclic derivatives HOFFMANN-LA ROCHE INC. (US) 2020-06-02 US disclosed
US-10669285-B2 Condensed [1,4] diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors HOFFMANN-LA ROCHE INC. (US) 2020-06-02 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed
US-5854407-A 15-hydroxy 6,9-hemiacetal erythromycin compounds TAKEDA CHEMICAL CORPORATION (JP) 1998-12-29 US disclosed
EP-0561413-B1 Erythromycin deriatives, preparation and use thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1996-06-05 EP disclosed
US-5470961-A 14 and/or 15-hydroxy 6,9 hemiacetal erythromycin derivatives TAKEDA CHEMICAL IND., LTD. (JP) 1995-11-28 US disclosed
EP-0561413-A1 Erythromycin deriatives, preparation and use thereof Takeda Chemical Industries, Ltd. (JP) 1993-09-22 EP disclosed
US-5175150-A Stimulating digective contraction KITASATO, KENKYUSHO (JP) 1992-12-29 US disclosed
US-5008249-A Administering anhydroerythromycin derivative KITASATO KENKYUSHO (JP) 1991-04-16 US disclosed
US-4948782-A A method of promoting the growth of domestic animals with erythromycin derivative containing composition KITASATO KENKYUSHO (JP) 1990-08-14 US disclosed
EP-0215355-A2 Erythromycin derivative and process for preparing the same KITASATO KENKYUSHO (JP) 1987-03-25 EP disclosed
EP-0213617-A2 Digestive tract contractile motion stimulant KITASATO KENKYUSHO (JP) 1987-03-11 EP disclosed